Learning Objectives:

1. Review the current status of anti-PD-1 antibody therapy in lymphoma

2. Discuss findings that suggest pd-l1 gene amplifications are associated with an inflamed DLBCL phenotype

3. Discuss how oncogenic pathways may promote immune cell exclusion from the lymphoma environment

Session date: 
01/22/2018 - 12:00pm to 1:00pm CST
University of Chicago Medicine
5841 South Maryland Avenue
MC2115, Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
James Godfrey, MD